A novel ChIP-spec technology to isolate protein complexes at unique genomic loci

一种新颖的 ChIP-spec 技术,可在独特的基因组位点分离蛋白质复合物

基本信息

  • 批准号:
    8586897
  • 负责人:
  • 金额:
    $ 24.38万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-12-01 至 2014-11-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The human genome contains protein coding genes, highly conserved non-coding elements, enhancer elements, insulator elements, and expansive transcriptionally silenced domains. Coordinated regulation of these genomic regions determines cellular identity. Determining the identity of proteins that interact with the genome is essential or understanding how the genome is regulated. A critical barrier to this goal has been the inability to purify and identify protein complexes on DNA while preserving native interactions. The ChIP-spec (Chromatin ImmunoPurification coupled to mass spectrometry) technology has the potential to overcome this problem by offering sequence specific purification of genomic loci and identification of bound regulatory factors in their native chromatinized context. The ChIP-spec technology works by introducing a "DNA sequence specific molecular handle" comprised of a DNA binding TAL (Transcription-Activator Like) affinity tag (TAL-tag) into a cell type of interest. After cross linking to preserve protein-protein and protein-DNA interactions, the chromatinized genome is sheared and the TAL-tag protein purified along with proteins bound to the targeted genomic region. Known and novel proteins are then identified by either standard immunodetection techniques or quantitative mass spectrometry. We propose to develop and deploy this novel technique to purify proteins and protein complexes that are bound to genomic loci in their native chromatinized context. This ChIP-spec technique will provide a powerful approach to dissecting genome regulatory mechanisms in development and disease by isolating and identifying putative regulatory proteins. We will develop our technology using well-established human model cell lines and deploy the technique in a test case to measure dynamic exchange of proteins during cellular differentiation. To reach these goals, we propose to 1) Develop the ChIP-spec technology to defined endpoints of affinity tag targeting, site specificity, and immunopurification using human model cell lines, 2) Couple the ChIP-spec technology to quantitative proteomic technologies to enable de novo detection of genomic regulatory proteins, and 3) Deploy the ChIP-spec assay to map protein complex dynamics during cellular differentiation. Purification of transcriptional regulatory complexes in human embryonic stem cells, somatic cells, and disease model cells are likely to provide new insights into how transcriptional regulation and the cell signaling contributes to cell specification and development. These complexes will also provide the foundation for future work developing gene regulatory models and motif finding algorithms. In medicine, this technique may facilitate new therapeutic approaches and provide new therapeutic targets for human disease. Finally, this work will determine the DNA binding specificities of TAL proteins in a human genomic context. Such information will be invaluable to human gene targeting and therapeutic genome editing efforts.
描述(由申请人提供):人类基因组包含蛋白质编码基因、高度保守的非编码元件、增强子元件、绝缘子元件和广泛的转录沉默结构域。这些基因组区域的协调调节决定细胞身份。确定与基因组相互作用的蛋白质的身份或了解基因组是如何调节的是必不可少的。这一目标的一个关键障碍是无法纯化和鉴定DNA上的蛋白质复合物,同时保留天然相互作用。ChIP-spec(染色质免疫纯化与质谱联用)技术有可能通过提供基因组位点的序列特异性纯化和在其天然染色质化背景下鉴定结合的调节因子来克服这一问题。ChIP-spec技术通过将由DNA结合TAL(转录激活因子样)亲和标签(TAL标签)组成的“DNA序列特异性分子手柄”引入感兴趣的细胞类型中来工作。 在交联以保持蛋白质-蛋白质和蛋白质-DNA相互作用后,剪切染色质化的基因组,并沿着与靶基因组区域结合的蛋白质一起纯化TAL-标签蛋白。然后通过标准免疫检测技术或定量质谱法鉴定已知的和新的蛋白质。我们建议开发和部署这种新的技术,以纯化蛋白质和蛋白质复合物,结合到基因组位点在其天然染色质化的情况下。 这种ChIP-spec技术将通过分离和鉴定推定的调控蛋白,为解剖发育和疾病中的基因组调控机制提供一种强有力的方法。我们将使用成熟的人类模型细胞系开发我们的技术,并将该技术部署在测试案例中,以测量细胞分化过程中蛋白质的动态交换。为了实现这些目标,我们建议1)开发ChIP-spec技术,以使用人类模型细胞系定义亲和标签靶向、位点特异性和免疫纯化的终点,2)将ChIP-spec技术与定量蛋白质组学技术结合,以实现基因组调控蛋白的从头检测,以及3)部署ChIP-spec测定以绘制细胞分化期间的蛋白质复合物动力学。 人胚胎干细胞、体细胞和疾病模型细胞中转录调控复合物的纯化可能为转录调控和细胞信号传导如何促进细胞特化和发育提供新的见解。这些复合物也将为未来开发基因调控模型和基序发现算法的工作提供基础。在医学上,该技术可能促进新的治疗方法,并为人类疾病提供新的治疗靶点。最后,这项工作将确定TAL蛋白在人类基因组背景下的DNA结合特异性。这些信息对于人类基因靶向和治疗性基因组编辑工作将是非常宝贵的。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RICHARD YOUNG其他文献

RICHARD YOUNG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RICHARD YOUNG', 18)}}的其他基金

Transcriptional regulation in mammalian cells
哺乳动物细胞的转录调控
  • 批准号:
    10668974
  • 财政年份:
    2022
  • 资助金额:
    $ 24.38万
  • 项目类别:
Transcriptional regulation in mammalian cells
哺乳动物细胞的转录调控
  • 批准号:
    10330858
  • 财政年份:
    2022
  • 资助金额:
    $ 24.38万
  • 项目类别:
A novel ChIP-spec technology to isolate protein complexes at unique genomic loci
一种新颖的 ChIP-spec 技术,可在独特的基因组位点分离蛋白质复合物
  • 批准号:
    8440468
  • 财政年份:
    2012
  • 资助金额:
    $ 24.38万
  • 项目类别:
Project 2: Investigating regulation of transcriptional condensates in multiple myeloma
项目 2:研究多发性骨髓瘤中转录缩合物的调控
  • 批准号:
    10555732
  • 财政年份:
    2011
  • 资助金额:
    $ 24.38万
  • 项目类别:
Discovery of small molecule inhibitors of c-Myc/Mac dimerization and DNA binding
发现 c-Myc/Mac 二聚化和 DNA 结合的小分子抑制剂
  • 批准号:
    8332272
  • 财政年份:
    2011
  • 资助金额:
    $ 24.38万
  • 项目类别:
Project 2. Investigating epigenetic circuitry in multiple myeloma
项目 2. 研究多发性骨髓瘤的表观遗传回路
  • 批准号:
    10226193
  • 财政年份:
    2011
  • 资助金额:
    $ 24.38万
  • 项目类别:
Discovery of small molecule inhibitors of c-Myc/Mac dimerization and DNA binding
发现 c-Myc/Mac 二聚化和 DNA 结合的小分子抑制剂
  • 批准号:
    8209617
  • 财政年份:
    2011
  • 资助金额:
    $ 24.38万
  • 项目类别:
Epigenomic Changes in Normal T-cell Development and Leukemogenesis
正常 T 细胞发育和白血病发生中的表观基因组变化
  • 批准号:
    7780952
  • 财政年份:
    2010
  • 资助金额:
    $ 24.38万
  • 项目类别:
Illumina Genome Analyzer IIx
Illumina 基因组分析仪 IIx
  • 批准号:
    7793700
  • 财政年份:
    2010
  • 资助金额:
    $ 24.38万
  • 项目类别:
Human Cell Cycle Transcriptional Regulatory Networks
人类细胞周期转录调控网络
  • 批准号:
    6823522
  • 财政年份:
    2004
  • 资助金额:
    $ 24.38万
  • 项目类别:

相似海外基金

DMS-EPSRC: Asymptotic Analysis of Online Training Algorithms in Machine Learning: Recurrent, Graphical, and Deep Neural Networks
DMS-EPSRC:机器学习中在线训练算法的渐近分析:循环、图形和深度神经网络
  • 批准号:
    EP/Y029089/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.38万
  • 项目类别:
    Research Grant
CAREER: Blessing of Nonconvexity in Machine Learning - Landscape Analysis and Efficient Algorithms
职业:机器学习中非凸性的祝福 - 景观分析和高效算法
  • 批准号:
    2337776
  • 财政年份:
    2024
  • 资助金额:
    $ 24.38万
  • 项目类别:
    Continuing Grant
CAREER: From Dynamic Algorithms to Fast Optimization and Back
职业:从动态算法到快速优化并返回
  • 批准号:
    2338816
  • 财政年份:
    2024
  • 资助金额:
    $ 24.38万
  • 项目类别:
    Continuing Grant
CAREER: Structured Minimax Optimization: Theory, Algorithms, and Applications in Robust Learning
职业:结构化极小极大优化:稳健学习中的理论、算法和应用
  • 批准号:
    2338846
  • 财政年份:
    2024
  • 资助金额:
    $ 24.38万
  • 项目类别:
    Continuing Grant
CRII: SaTC: Reliable Hardware Architectures Against Side-Channel Attacks for Post-Quantum Cryptographic Algorithms
CRII:SaTC:针对后量子密码算法的侧通道攻击的可靠硬件架构
  • 批准号:
    2348261
  • 财政年份:
    2024
  • 资助金额:
    $ 24.38万
  • 项目类别:
    Standard Grant
CRII: AF: The Impact of Knowledge on the Performance of Distributed Algorithms
CRII:AF:知识对分布式算法性能的影响
  • 批准号:
    2348346
  • 财政年份:
    2024
  • 资助金额:
    $ 24.38万
  • 项目类别:
    Standard Grant
CRII: CSR: From Bloom Filters to Noise Reduction Streaming Algorithms
CRII:CSR:从布隆过滤器到降噪流算法
  • 批准号:
    2348457
  • 财政年份:
    2024
  • 资助金额:
    $ 24.38万
  • 项目类别:
    Standard Grant
EAGER: Search-Accelerated Markov Chain Monte Carlo Algorithms for Bayesian Neural Networks and Trillion-Dimensional Problems
EAGER:贝叶斯神经网络和万亿维问题的搜索加速马尔可夫链蒙特卡罗算法
  • 批准号:
    2404989
  • 财政年份:
    2024
  • 资助金额:
    $ 24.38万
  • 项目类别:
    Standard Grant
CAREER: Efficient Algorithms for Modern Computer Architecture
职业:现代计算机架构的高效算法
  • 批准号:
    2339310
  • 财政年份:
    2024
  • 资助金额:
    $ 24.38万
  • 项目类别:
    Continuing Grant
CAREER: Improving Real-world Performance of AI Biosignal Algorithms
职业:提高人工智能生物信号算法的实际性能
  • 批准号:
    2339669
  • 财政年份:
    2024
  • 资助金额:
    $ 24.38万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了